Nexavar (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Nexavar drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | sorafenib |
| SUBSTANCE NAME: | SORAFENIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-12-20 |
| END MARKETING DATE: | 0000-00-00 |
Nexavar HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nexavar from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2005-12-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-488_c614a52e-7ba4-4adb-b11c-d34bc7165dd6 |
| PRODUCT NDC: | 50419-488 |
| APPLICATION NUMBER: | NDA021923 |
Other SORAFENIB Pharmaceutical Manufacturers / Labelers:
